Meanwhile she started semaglutide 3 mg orally in April 2024, titrated to 7 mg after 20 days for glucose intolerance (abnormal oral glucose tolerance test) prescribed by her endocrinologist, with normal levels of HbA1c and fasting glucose)
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes
WuQet al
Bettelheim P, Valent P, Andreeff M , Tafuri A, Haimi J, Gorischek C, Muhm M, Sillaber C, Haas O, Vieder L, et al
Research shows that 30-40% of weight lost on GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can be lean muscle mass if no preventive measures are taken
1 - 3 The most common side effects experienced by patients treated with GLP-1 RAs are gastrointestinal (GI) in nature, including nausea, vomiting, and diarrhea